CRL

Charles River Laboratories

$175.46

+7.9 (+4.71%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 27.02.2026
$197.20
(+12.39%)
Strong Buy: 1
Buy: 10
Hold: 7
Sell: 0
Strong Sell: 0
Description:
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Exchange:
NYSE
Country:
USA
Sector:
HEALTHCARE
Industry:
DIAGNOSTICS & RESEARCH
Address:
251 BALLARDVALE STREET, WILMINGTON, MA, UNITED STATES, 01887
Fiscal year end:
December
Market capitalization:
$8.25 Billion
EBITDA:
$877 Million
PERatio:
0.0
EPS:
-1.52
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.62

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+184%
How much will you get:
$2,836
Prices dates:
29-01-2016: $74.23 and 30-01-2026: $210.48